1 |
The evolving landscape of PARP inhibitors in castration-resistant prostate cancer: a spotlight on treatment combinations |
|
|
| Benjamin A. Teply, Emmanuel S. Antonarakis |
|
| Expert Review of Clinical Pharmacology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Inhibition of Mps1 kinase enhances taxanes efficacy in castration resistant prostate cancer |
|
|
| Sadia Sarwar, Viacheslav M. Morozov, Hamsa Purayil, Yehia Daaka, Alexander M. Ishov |
|
| Cell Death & Disease. 2022; 13(10) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population |
|
|
| Giacomo Canesin, Valentina Maggio, Macarena Palominos, Anna Stiehm, Hector R. Contreras, Enrique A. Castellón, Juan Morote, Rosanna Paciucci, Norman J. Maitland, Anders Bjartell, Rebecka Hellsten |
|
| Scientific Reports. 2020; 10(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling |
|
|
| Sakthivel Muniyan, Satyanarayana Rachagani, Seema Parte, Sushanta Halder, Parthasarathy Seshacharyulu, Prakash Kshirsagar, Jawed A. Siddiqui, Raghupathy Vengoji, Sanchita Rauth, Ridwan Islam, Kavita Mallya, Kaustubh Datta, Lei Xi, Anindita Das, Benjamin A. Teply, Rakesh C. Kukreja, Surinder K. Batra |
|
| Clinical Cancer Research. 2020; 26(21): 5720 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Aurora B Kinase Promotes CHIP-Dependent Degradation of HIF1a in Prostate Cancer Cells |
|
|
| Kuntal Biswas, Sukumar Sarkar, Neveen Said, David L. Brautigan, James M. Larner |
|
| Molecular Cancer Therapeutics. 2020; 19(4): 1008 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer |
|
|
| Chaojiang Chen, Zhiduan Cai, Yangjia Zhuo, Ming Xi, Zhuoyuan Lin, Funeng Jiang, Zezhen Liu, Yueping Wan, Yu Zheng, Jianxin Li, Xing Zhou, Jianguo Zhu, Weide Zhong |
|
| BMC Cancer. 2020; 20(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Improving adenoviral vectors and strategies for prostate cancer gene therapy |
|
|
| Rodrigo Esaki Tamura, Igor Vieira de Luna, Marlous Gomes Lana, Bryan E Strauss |
|
| Clinics. 2018; 73: e476s |
|
| [Pubmed] [Google Scholar] [DOI] |
|